Aigen Investment Management LP Invests $1.41 Million in STERIS plc (NYSE:STE)

Aigen Investment Management LP acquired a new stake in shares of STERIS plc (NYSE:STE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,870 shares of the medical equipment provider's stock, valued at approximately $1,412,000.

Several other institutional investors have also bought and sold shares of STE. Franklin Resources Inc. lifted its position in STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Boston Trust Walden Corp lifted its holdings in shares of STERIS by 400.4% in the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider's stock worth $46,198,000 after acquiring an additional 179,829 shares during the last quarter. Swedbank AB bought a new stake in shares of STERIS in the 3rd quarter worth about $28,251,000. Benjamin Edwards Inc. lifted its holdings in shares of STERIS by 2,123.2% in the 3rd quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider's stock worth $27,574,000 after acquiring an additional 108,559 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of STERIS by 9.5% in the 3rd quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock worth $270,230,000 after acquiring an additional 96,336 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

STERIS Trading Up 0.3 %

STE traded up $0.77 on Friday, reaching $233.02. 667,376 shares of the company traded hands, compared to its average volume of 519,679. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The firm has a fifty day simple moving average of $216.96 and a two-hundred day simple moving average of $222.78. The company has a market cap of $22.89 billion, a P/E ratio of 49.47 and a beta of 0.92. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS's dividend payout ratio (DPR) is 48.41%.

Analysts Set New Price Targets

Several research firms have recently issued reports on STE. Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. JMP Securities restated a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Finally, Stephens restated an "overweight" rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, STERIS presently has a consensus rating of "Moderate Buy" and an average price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.